Dubai-based logistics provider, Aramex, has announced its partnership with fellow Dubai company, NewBridge Pharmaceuticals, to provide a range of logistics services in the Middle East, Africa, Canada and the UK.
Through the partnership, Aramex is managing the logistics of patient samples across any clinics and hospitals from the Middle East to the US for advanced clinical testing.
Aramex is also providing temperature-controlled storage and transportation of medication, customs clearance, secondary packaging, labeling, vaulting and guarded transport services.
Hussein Hachem, CEO of Aramex, said: “We are excited to have partnered with NewBridge Pharmaceuticals. This collaboration is a testimony to our healthcare solutions, which not only enable our healthcare customers to grow globally, but also provide access to quality healthcare service to citizens across our region.”
Joe Henein, CEO of NewBridge Pharmaceuticals, said: “This partnership with Aramex gives us significant opportunities to expand our business proposition and take advantage of the increasing demand for our solutions across the Middle East and Africa.
“We are dedicated to addressing the medical needs of our customers and this partnership allows us to reach more businesses and patients who rely on our full range of pharmaceutical services.
“We remain committed to servicing the Middle East and Africa and this partnership will allow us to serve more businesses and consumers who need critical medical attention in the region.”
In addition to having facility hubs based in the UK and Canada, Aramex plans to set up a third facility hub in the U.S. soon, and will continue to handle the storage, transport and delivery of NewBridge’s medicine and other pharmaceutical goods.